Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity.

Por Brasoveanu, L I, Fonsatti, E, Visintin, A, Pavlovic, M, Cattarossi, I, Colizzi, F, Gasparollo, A, Coral, S, Horejsi, V, Altomonte, M, Maio, M
Publicado em 1997

Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications

Por Coral, S, Covre, A, JMG Nicolay, H, Parisi, G, Rizzo, A, Colizzi, F, Dalla Santa, S, Fonsatti, E, Fratta, E, Sigalotti, L, Maio, M
Publicado em 2012

Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma.

Por Altomonte, M., Montagner, R., Fonsatti, E., Colizzi, F., Cattarossi, I., Brasoveanu, L. I., Nicotra, M. R., Cattelan, A., Natali, P. G., Maio, M.
Publicado em 1996

Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models

Por Covre, A, Coral, S, Nicolay, H, Parisi, G, Fazio, C, Colizzi, F, Fratta, E, Di Giacomo, A M, Sigalotti, L, Natali, P G, Maio, M
Publicado no Oncoimmunology (2015)

Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications

Por Sigalotti, L, Coral, S, Altomonte, M, Natali, L, Gaudino, G, Cacciotti, P, Libener, R, Colizzi, F, Vianale, G, Martini, F, Tognon, M, Jungbluth, A, Cebon, J, Maraskovsky, E, Mutti, L, Maio, M
Publicado em 2002